Literature review of similar cases published since 2015
| Author and year of publication | Country | Gender | Age | Stage of disease | Surgical margins | Adjuvant/neoadjuvant therapy | Outcomes |
| Mandal (2021)13 | USA | Female | 76 | T4N0M0 | NA | Neoadjuvant chemo | Palliated death |
| Akce (2019) retrospective analysis of National Database from 2004 to 201314 | USA | 70 male 146 female (data available for 175 patients) | 67 (median) | 106 with T3 disease, 14 with T4 disease, 119 with N1 and 4 with M1 disease | 69 involved margin and 98 clear margins | 4 patients with neoadjuvant and 77 patients with adjuvant therapy | 12 months survival 34.5% 60 months survival 13.9% |
| Gyawali (2023)15 | Nepal | Female | 70 | T2bN1 | Clear margins | Not stated | Alive 2 years postoperative |
| Tidjane (2022)16 | Algeria | Female | 82 | T2bN1M0 | Clear margins | Oral adjuvant chemo | Alive at 2 years postoperative |
NA, not available.